Avestar Capital, LLC Viatris Inc Transaction History

Avestar Capital, LLC

$951 Million
Q3 2024

A detailed history of Avestar Capital, LLC transactions in Viatris Inc stock. As of the latest transaction made, Avestar Capital, LLC holds 39,071 shares of VTRS stock, worth $483,698. This represents 0.05% of its overall portfolio holdings.

Number of Shares

39,071

Previous 29,532 32.3%

Holding current value

$483,698

Previous $313,000 44.73%

% of portfolio

0.05%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.32 - $12.13 $98,442 - $115,708	9,539 Added 32.3%	39,071 $453,000
Q2 2024 Aug 08, 2024	SELL	$10.05 - $12.02 $868,822 - $1.04 Million	-86,450 Reduced 74.54%	29,532 $313,000
Q1 2024 May 10, 2024	BUY	$11.27 - $13.53 $723,071 - $868,071	64,159 Added 123.8%	115,982 $1.38 Million
Q4 2023 Feb 12, 2024	SELL	$8.77 - $10.85 $359,254 - $444,459	-40,964 Reduced 44.15%	51,823 $561,000
Q3 2023 Oct 20, 2023	BUY	$9.59 - $11.35 $30,918 - $36,592	3,224 Added 3.6%	92,787 $914,000
Q2 2023 Aug 01, 2023	BUY	$9.02 - $10.29 $14,251 - $16,258	1,580 Added 1.8%	89,563 $893,000
Q1 2023 Apr 20, 2023	SELL	$9.2 - $12.26 $173,162 - $230,757	-18,822 Reduced 17.62%	87,983 $846,000
Q4 2022 Jan 20, 2023	BUY	$8.72 - $11.56 $21,704 - $28,772	2,489 Added 2.39%	106,805 $0
Q3 2022 Oct 26, 2022	BUY	$8.48 - $11.13 $370,474 - $486,247	43,688 Added 72.06%	104,316 $889,000
Q2 2022 Jul 28, 2022	SELL	$9.95 - $12.27 $327,663 - $404,063	-32,931 Reduced 35.2%	60,628 $635,000
Q1 2022 Apr 26, 2022	BUY	$9.81 - $15.4 $61,135 - $95,972	6,232 Added 7.14%	93,559 $1.02 Million
Q4 2021 Feb 01, 2022	BUY	$12.09 - $14.68 $1.06 Million - $1.28 Million	87,327 New	87,327 $1.18 Million

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Account

Avestar Capital, LLC Viatris Inc Transaction History